The Motley Fool

Auscann Group Holdings Ltd (ASX: AC8) Share Price and News

() Chart and Price Data

(20 mins delayed)

.

Price
Bid/Ask /
Volume
Avg Daily Volume
Day Movement
Day High/Low /
52 Week Range -
Year Return (Capital)
As at

Auscann Group Holdings Ltd (ASX: AC8) is a pharmaceutical company based in Western Australia. Its focus is on developing, producing and distributing a range of cannabinoid treatments for use in Australia and internationally.

According to Auscann, the company’s products are the result of a stringent development program that aims to produce stable and effective cannabinoid-based medicines. Auscann also seeks to generate clinical evidence supporting the efficacy of its products to support further market penetration.

Whilst working directly with patients, Auscann’s primary focus is on providing healthcare professionals with optimal treatment solutions to help them better care for their patients. The company also provides healthcare professionals with the tools to personalise and adjust dosage and treatment programs for each individual.

AusCann was readmitted to the ASX in early 2017 after it was acquired by the already listed company TW Holdings Limited. In the months following, the Auscann share price surged by nearly 200%. Within 12 months, the Auscann share price had gone on to deliver growth of nearly 500% over its ASX readmittance value. Since then however, the Auscann share price has trended lower and has not traded over $1 since late 2018.

Auscann Group Holdings Ltd (ASX: AC8) Latest News

medical cannabis

Is it time to buy into these three ASX cannabis shares?

It's been a while since there was much life in ASX cannabis shares. But as the industry matures, it's offering new investment opportunities. More »


Cannabis shares

Auscann (ASX:AC8) share price up 6% on phase I study results

The Auscann Group Holdings Ltd (ASX: AC8) share price has smoked the market today, thanks to the results of its completed Neuvis Phase I... More »


cannabis leaves on a rising line graph representing emerald clinic share price

Why Althea (ASX:AGH) and these ASX cannabis shares are smoking the market today

The Althea Group Holdings Ltd (ASX:AGH) share price and fellow cannabis companies are rocketing higher on Wednesday. Here's why... More »


Bottles and vials of hemp oil in a row next to a spoon filled with hemp seeds representing asx cannabis shares

ASX cannabis shares continue progress despite pandemic

ASX cannabis shares have reported they've been continuing to work through COVID-19 disruptions as they look to scale their businesses. More »


Cannabis shares

ASX cannabis shares adjust to coronavirus environment

As the Australian medicinal cannabis industry grows, we take a look at how ASX cannabis shares are facing the coronavirus challenge. More »


medical cannabis

Althea share price lifts as cannabis market growth predicted

The Althea share price is on the rise today following the announcement its subsidiary has entered a cannabis beverage production agreement. More »


Downward trend

Why AusCann, Phoslock, Kogan, & Village Roadshow are dropping lower

Kogan.com Ltd (ASX:KGN) and Village Roadshow Ltd (ASX:VRL) are two of four ASX shares dropping lower on Tuesday. Here's why... More »


medical cannabis

ASX cannabis shares see mixed recovery

We take a look at the recovery of ASX cannabis shares through the likes of Althea Group Holdings after the March market correction. More »


medical cannabis

How did ASX cannabis shares perform in the latest quarter?

ASX cannabis shares have faced a difficult few months. Struck by a capital crunch earlier this year, cannabis shares were then hammered in the... More »


medical marijuana, cannabis, pot, drug, medical

ASX cannabis shares stage a comeback after the March bear market

ASX cannabis shares are staging a comeback after the March share market correction. More »


medical cannabis

ASX cannabis shares grow business despite coronavirus downturn

While the market has been distracted by the fallout from the coronavirus pandemic, ASX cannabis shares have been quietly expanding their businesses. We take... More »


Medical Cannabis

Here’s how ASX cannabis shares are being impacted by COVID-19

Althea Group Holdings Ltd (ASX:AGH) and other ASX cannabis shares have fallen heavily this month because of the coronavirus. Will it continue? More »


medical marijuana, cannabis, pot, drug, medical

How did ASX cannabis shares perform this reporting season?

As February reporting season wraps up, let's take a look at how these ASX cannabis shares performed. More »


Why Afterpay, AMA, AusCann, & Harvey Norman are dropping lower

Afterpay Ltd (ASX:APT) and Harvey Norman Holdings Limited (ASX:HVN) shares are two of four dropping notably lower on Friday... More »